Peter Redmond

Mr. Peter Redmond is an Independent Non-Executive Director at HemoGenyx Pharmaceuticals Plc.
He is on the Board of Directors at HemoGenyx Pharmaceuticals Plc, Armstrong Investments Ltd., Be Heard Group Ltd., BigBlu Operations Ltd., Catalyst Consultancy Ltd., Energy Investment Opportunities Ltd. and Gem Resources Plc.
Mr. Redmond was previously employed as a Non-Executive Director by Ananda Developments Plc, a Non-Executive Director by Gem Resources Plc, a Non-Executive Director by Silver Falcon Plc, an Executive Director by Armstrong Ventures Plc, a Secretary & Director by Cleeve Capital Plc, an Independent Non-Executive Chairman & Secretary by Mithril Capital Plc, a Chairman by Pires Investments Plc, an Executive Chairman by Leed Resources Plc, a Non-Executive Director by Renewable Power & Light Plc, a Director-Corporate Finance by Durlacher Ltd., a Principal by Artilium Group Ltd., an Independent Non-Executive Director by Dukemount Capital plc, a Principal by Invex Investments Ltd., a Chief Executive Officer by Merchant House Group Plc, a Non-Executive Director by IGas Energy Plc, and a Non-Executive Director by Weatherly International Plc.
He also served on the board at Kennedy Ventures Plc, Bella Media Plc, 3Legs Resources Plc, Blenheim Energy Ltd., Blenheim Wind & Biomass Ltd., Blenheim Wind (UK) Plc, Catalyst Corporate Consultants Ltd., CityPoint Holdings Ltd., Devonshire Wind Projects Ltd., DS Finance & Leasing Ltd., KP Renewables Plc and SalvaRx Group Plc.